[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Von dem Borne et al., 1977 - Google Patents

IgG4 autoantibodies against erythrocytes, without increased haemolysis: a case report

Von dem Borne et al., 1977

Document ID
3345307017713500014
Author
Von dem Borne A
Beckers D
Van Der Meulen F
Engelfriet C
Publication year
Publication venue
British journal of haematology

External Links

Snippet

A patient is described who, notwithstanding a strongly positive direct antiglobulin test with anti‐IgG serum, apparently did not suffer from haemolytic anaemia. The survival of the patient's red cells, measured with 51Cr, was only slightly decreased. In vitro, the sensitized …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Atkinson et al. Studies on the in vivo effects of antibody interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man
Pierce et al. IMMUNE RESPONSES IN VITRO: III. Development of Primary γM, γG, and γA Plaque-Forming Cell Responses in Mouse Spleen Cell Cultures Stimulated with Heterologous Erythrocytes
Bluestein et al. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus.
Cochrane et al. Studies on circulating immune complexes: III. Factors governing the ability of circulating complexes to localize in blood vessels
Karpatkin et al. Detection of splenic anti‐platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP)
Hamburger et al. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus
Kelton et al. A prospective comparison of four techniques for measuring platelet‐associated IgG
Clark et al. Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms
Diamond et al. The importance of Rh inhibitor substance in anti-Rh serums
Von dem Borne et al. IgG4 autoantibodies against erythrocytes, without increased haemolysis: a case report
Fialkow et al. “Acquired” antibody hemolytic anemia and familial aberrations in gamma globulins
Fessel The Antibrain Factors in Psychiatric Patients' Sera: I. Further Studies With a Hemagglutination Technique
Hsu et al. Instrumented PVP-augmented antiglobulin tests
Baumal et al. Studies into the occurrence of soluble antigen–antibody complexes in disease. III. Rheumatoid arthritis and other human diseases
YOUNG et al. Clinical and laboratory observations on autoimmune hemolytic disease
Fleer et al. Destruction of IgG‐sensitized erythrocytes by human blood monocytes: modulation of inhibition by IgG
JPH03500087A (en) Antibody-binding platelet immunoassay
Koller et al. Lupus erythematosus cell preparation-antinuclear factor incongruity: a review of diagnostic tests for systemic lupus erythematosus
Butler Some studies on the naturally occurring leucocyte agglutinins
Sokol et al. ACP Broadsheet No. 145: July 1995. Investigation of patients with autoimmune haemolytic anaemia and provision of blood for transfusion.
Steward et al. Circulating antigen-antibody complexes in onchocerciasis.
Strauss et al. Alloimmunization in preterm infants after repeated transfusions of WBC‐reduced RBCs from the same donor
Rosenfield et al. Complement and the antiglobulin test
Lane et al. Serological and biochemical analysis of the PlA1 alloantigen of human platelets
Wild et al. C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.